Glossary of Important Terms
Definitions and important concepts about medical cannabis (marijuana)
Database of Clinical Research and Case Reports
A database of clinical research and case reports, from the last 30 years, maintained by the International Association for Cannabis.
Medical Cannabis Research: What Does the Evidence Say?
Health and Human Services claims that “marijuana has no currently accepted medical use in treatment in the United States.” However, more than 6,500 reports and journal articles from around the world support the medical value of cannabis (marijuana). Here is an overview of the latest research.
A History of Medical Marijuana August 16th, 2005
A thorough history of medical marijuana prepared by medical marijuana expert, Dr. Lester Grinspoon.
National Institute of Health Workshop on Medical Marijuana
In 1997 the National Institutes of Health held a 2-day scientific meeting about medical marijuana. According to the panel, research is justified into symptoms of certain conditions including pain, neurological and movement disorders, nausea, loss of appetite and severe weight loss, and glaucoma.
“Marijuana and Medicine: Assessing the Science Base”
In 1999, the Institute of Medicine released their report, on the potential health benefits and risks of marijuana. They stress the need for more scientific research.
Cannabis in painful HIV-associated sensory neuropathy – Abstract and Full Study
Based on the effects of cannabinoids in pre-clinical models of neuropathic pain and anecdotal case reports, a controlled trial of smoked cannabis was conducted.
Missoula Chronic Clinical Cannabis Use Study
In this study designed to examine the long term effects of smoked cannabis, researchers reviewed the overall health of patients who have used medical marijuana legally under federal law for 11-27 years. Results demonstrate clinical effectiveness in treating glaucoma, chronic musculoskeletal pain, spasm and nausea, and spasticity of multiple sclerosis.
Cannabinoid Receptor as Therapeutic Targets
by Ken Mackie, Annual Review of Pharmacology and Toxicology
March 14th, 2006
The Emerging Role of the Endocannabinoid System in Endocrine Regulation and Energy Balance
by Uberto Pagotto, Giovanni Marsicano, Daniela Cota, Beat Lutz, and Renato Pasquali, Endocrine Reviews February 1st, 2006
The Classification of Cannabis under the Misuse of Drugs Act 1971 (2002)
The United Kingdom’s Advisory Council on the Misuse of Drugs recommends the reclassification of all Cannabis preparations from Class B to Class C.
The Advisory Council’s Report – Further consideration of the classification of cannabis under the Misuse of Drugs Act 1971 (2005)
In light of new research, the United Kingdom’s Advisory Council reviewed its position on the classification of cannabis products in light of new research. This new report confirms the Council’s 2002 decision.